In the BioHarmony Drug Report Database

"Preview" Icon

Flumazenil

Romazicon (flumazenil) is a small molecule pharmaceutical. Flumazenil was first approved as Romazicon on 1991-12-20. It is used to treat drug overdose in the USA. The pharmaceutical is active against gamma-aminobutyric acid receptor subunit alpha-1, gamma-aminobutyric acid receptor subunit alpha-5, gamma-aminobutyric acid receptor subunit alpha-2, and gamma-aminobutyric acid receptor subunit alpha-3. In addition, it is known to target gamma-aminobutyric acid receptor subunit alpha-6 and gamma-aminobutyric acid receptor subunit alpha-4.

 

Trade Name

 

Romazicon
 

Common Name

 

flumazenil
 

ChEMBL ID

 

CHEMBL407
 

Indication

 

drug overdose
 

Drug Class

 

Benzodiazepine receptor (agonists/antagonists)

Image (chem structure or protein)

Flumazenil structure rendering